mouse tff2 (Biosynth Carbosynth)
Structured Review

Mouse Tff2, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse tff2/product/Biosynth Carbosynth
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Therapeutic potential of adenovirus-mediated TFF2-CTP-Flag peptide for treatment of colorectal cancer."
Article Title: Therapeutic potential of adenovirus-mediated TFF2-CTP-Flag peptide for treatment of colorectal cancer.
Journal: Cancer gene therapy
doi: 10.1038/s41417-018-0036-z
Figure Legend Snippet: Fig. 3 Validation of Ad-Tff2-CTP-Flag activity in AOM/DSS-induced colon cancer model. a, b Ad-Tff2 suppresses colon tumorigenesis in wild- type mice treated with AOM/DSS. a Colon appearance (left), tumor number (right), b number of splenic CD11b+Gr-1+ cells. Two experiments have been done with 3–4 mice in each group. c, d Ad Tff2-CTP-Flag suppresses colon tumorigenesis in AOM/DSS-induced colon cancer model. c Colon appearance and tumor number, d proportion CD11b+Gr-1+ cells in the spleen from wild-type mice treated with Ad-Tff2-CTP versus Ad- Fc-CTP, unpaired t-test, *p < 0.05. Two experiments have been done with 3–4 mice in each group. e Overlapping staining for Flag and Gr-1 in the spleen of Tff2-null mice injected with Ad-Tff2-CTP-Flag. Mice were given 2% DSS for 5 consecutive days, then seven days later adenovirus was administrated via tail vein and mice were sacrificed in one week after adenovirus administration. Bar size is 50 µm. f BrdU incorporation in splenic CD11b+Gr-1+ cells of wild-type mice injected with Ad-Fc-CTP-Flag compare with Ad-Tff2-CTP-Flag, unpaired t-test. Wild-type mice were treated 2% DSS for 5 consecutive days, then on day 7 post treatment with DSS single injection of Ad-Tff2-CTP or Ad-Fc-CTP-Flag (both 5 × 108
Techniques Used: Biomarker Discovery, Activity Assay, Staining, Injection, BrdU Incorporation Assay




